Secondary Logo

Journal Logo

Errata

Establishing Sickle Cell Disease Stroke Prevention Teams in Africa is Feasible: Program Evaluation Using the RE-AIM Framework: Erratum

Journal of Pediatric Hematology/Oncology: May 2022 - Volume 44 - Issue 4 - p 193
doi: 10.1097/MPH.0000000000002471
  • Free

In the article by Establishing Sickle Cell Disease Stroke Prevention Teams in Africa is Feasible: Program Evaluation Using the RE-AIM Framework, et al that was published in J Pediatr Hematol Oncol (2022 Jan 1;44(1):e56-e61) many of the references were incorrect.1

Reference Kwaitkowski reference #5 should be number 3; Ware reference #17 should be number 2; Adams RJ reference #4 should be reference #5; Delete Boyd reference #22 in the reference list and text.

New reference #4 and #17

4. Enninful-Eghan H, Moore RH, Ichord R, Smith-Whitley K, Kwiatkowski JL. Transcranial Doppler ultrasonography and prophylactic transfusion program is effective in preventing overt stroke in children with sickle cell disease. J Pediatr. 2010 Sep;157(3):479–484.

17. Galadanci NA, Abdullahi SU, Ali Abubakar S, et al. Moderate fixed-dose hydroxyurea for primary prevention of strokes in Nigerian children with sickle cell disease: final results of the SPIN trial. Am J Hematol. 2020 Sep;95(9):E247–E250.

Also the references were incorrect in the following sentences. The correct references are listed.

Page 1- line 9, As a result of standard care practice in high-income countries, the stroke incidence rate has dropped in children with SCA by 10-fold.3,4 Not reference 4, 5.

Page 5- line 3, ∼40 strokes using the number-needed-to-treat to prevent 1 stroke (NNT=7) from the STOP trial and assuming equal efficacy, ∼<1 event per 100 person-years.5 Not reference 4, 17.

Page 1- line 8, After 1 year of regular blood transfusion therapy, hydroxyurea therapy may be used in children without cerebral vasculopathy.2 Not reference 3.

Page 1- line 12, Children with abnormal TCD velocities, ∼20% will have a stroke over 2 years if not treated with regular blood transfusion or hydroxyurea therapy, based on an incidence rate of 10.9 strokes per 100 person-years.5 Not 4, and 5.

Page 2- line 14, On the basis of the STOP protocol.5 Not 4.

Page 2- line 27, The TCD-certified non-radiologist physicians and nurses were also trained and certified on the Pediatric NIH Stroke Scale (PedNIHSS), a validated, standardized neurological examination assessing and quantifying the severity of strokes in children.13 Not 13-15.

Page 2–32. Each participant performed a minimum of 10 observed neurological examinations in children.14,15 No reference was listed and there should be the two references listed.

REFERENCE

1. Ghafuri DL, Abdullahi SU, Dambatta AH, et al. Establishing sickle cell disease stroke prevention teams in Africa is feasible: program evaluation using the RE-AIM framework. J Pediatr Hematol Oncol. 2022;44:e56–e61.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.